SECURITIES AND EXCHANGE COMMISSION
                            Washington, DC  20549

                                  FORM 8-K


              Current Report Pursuant to Section 13 or 15(d) of
                     The Securities Exchange Act of 1934

      Date of Report (Date of Earliest Event Reported):  July 24, 2003

                           HAEMONETICS CORPORATION
           (Exact Name of Registrant as Specified in its Charter)

         Massachusetts                1-10730              04-2882273
-------------------------------   ----------------   ----------------------
(State or other jurisdiction of   (Commission File       (IRS Employer
incorporation or organization)        Number)        Identification Number)


            400 Wood Road
            Braintree, MA                               02184
        ---------------------                        ----------
        (Address of principal                        (Zip Code)
         executive offices)


      Registrant's telephone number, including area code (781) 848-7100





Item 9.  Regulation FD Disclosure.
----------------------------------

      The following information is intended to be included under "Item 12.
Results of Operations and Financial Condition" and is included under this
Item 9 in accordance with SEC Release No. 33-8216.

      On July 24,2003 Haemonetics Corporation (the "Company") issued a
press release regarding its financial results for the quarter ended June
28, 2003. The Company's press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K.

      The information in this Current Report on Form 8-K and the Exhibit
attached hereto shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise
subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933 or
the Exchange Act, regardless of any general incorporation language in such
filing.


Exhibits
--------

99.1   Press Release dated July 24, 2003, of Haemonetics Corporation.


  2


                                 SIGNATURES


      Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                    HAEMONETICS CORPORATION


Date:  July 24, 2003                By:  s/Ronald  J. Ryan
      ---------------                   ---------------------------------------
                                         Ronald J. Ryan, Senior Vice President
                                         and Chief Financial Officer


  3